It induces apoptosis in MCF-7 breast cancer cells by increasing ROS levels and regulating pro-apoptotic proteins such as Bax and p53 while reducing Bcl-2 and cyclin D1 expression and activating caspase-3. Here, CASP3 is linked to breast carcinoma.